This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McGee, D W Articles by McGhee, J R Search for Related Content PubMed PubMed Citation Articles by McGee, D W Articles by McGhee, J R

Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines.

Department of Microbiology, University of Alabama, Birmingham Medical Center 35294.

ABSTRACT

Oral administration of cholera toxin (CT) induces a strong mucosal immune response to CT as well as having a potent adjuvant effect. Since one of the first cell types to encounter CT during cholera infection or after oral administration is the epithelial cell, we studied the effect of CT on interleukin-6 (IL-6) secretion by the rat intestinal epithelial cell line IEC-6. CT was found to rapidly enhance IL-6 secretion and IL-6 gene expression by these cells. The addition of dibutyryl cyclic AMP (cAMP) to cultures of IEC-6 cells had little effect on IL-6 secretion, yet mRNA levels were elevated, suggesting that the response may have been regulated by cAMP. Purified B subunit of CT did not significantly enhance IL-6 secretion or mRNA expression. CT and transforming growth factor beta 1 synergistically enhanced IL-6 secretion in IEC-6 cells. The addition of CT with either IL-1 beta or tumor necrosis factor alpha gave even greater synergistic enhancement of IL-6 secretion, and dibutyryl cAMP could mimic CT's synergy with IL-1 beta. These results indicate that the intestinal epithelial cell is capable of secreting high levels of IL-6 after encountering CT, especially in the presence of inflammatory cytokines. This high level of IL-6 secretion could be a very important component of the mucosal immune response to CT and may also account for a portion of the adjuvant effect of CT.

This article has been cited by other articles:

• Duverger, A., Jackson, R. J., van Ginkel, F. W., Fischer, R., Tafaro, A., Leppla, S. H., Fujihashi, K., Kiyono, H., McGhee, J. R., Boyaka, P. N. (2006). Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens. J. Immunol. 176: 1776-1783 [Abstract] [Full Text]  
• van Ginkel, F. W., Jackson, R. J., Yoshino, N., Hagiwara, Y., Metzger, D. J., Connell, T. D., Vu, H. L., Martin, M., Fujihashi, K., McGhee, J. R. (2005). Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract. Infect. Immun. 73: 6892-6902 [Abstract] [Full Text]  
• Flach, C.-F., Lange, S., Jennische, E., Lonnroth, I., Holmgren, J. (2005). Cholera Toxin Induces a Transient Depletion of CD8+ Intraepithelial Lymphocytes in the Rat Small Intestine as Detected by Microarray and Immunohistochemistry. Infect. Immun. 73: 5595-5602 [Abstract] [Full Text]  
• Hershko, D. D., Robb, B. W., Luo, G., Hasselgren, P.-O. (2002). Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R1140-R1148 [Abstract] [Full Text]  
• Soriani, M., Bailey, L., Hirst, T. R. (2002). Contribution of the ADP-ribosylating and receptor-binding properties of cholera-like enterotoxins in modulating cytokine secretion by human intestinal epithelial cells. Microbiology 148: 667-676 [Abstract] [Full Text]  
• Staats, H. F., Bradney, C. P., Gwinn, W. M., Jackson, S. S., Sempowski, G. D., Liao, H.-X., Letvin, N. L., Haynes, B. F. (2001). Cytokine Requirements for Induction of Systemic and Mucosal CTL After Nasal Immunization. J. Immunol. 167: 5386-5394 [Abstract] [Full Text]  
• Yoshida, H., Miura, S., Kishikawa, H., Hirokawa, M., Nakamizo, H., Nakatsumi, R. C., Suzuki, H., Saito, H., Ishii, H. (2001). Fatty Acids Enhance GRO/CINC-1 and Interleukin-6 Production in Rat Intestinal Epithelial Cells. J. Nutr. 131: 2943-2950 [Abstract] [Full Text]  
• Murthy, S., Mathur, S. N., Field, F. J. (2000). Tumor Necrosis Factor-alpha and Interleukin-1beta Inhibit Apolipoprotein B Secretion in CaCo-2 Cells via the Epidermal Growth Factor Receptor Signaling Pathway. J. Biol. Chem. 275: 9222-9229 [Abstract] [Full Text]  
• Williamson, E., Westrich, G. M., Viney, J. L. (1999). Modulating Dendritic Cells to Optimize Mucosal Immunization Protocols. J. Immunol. 163: 3668-3675 [Abstract] [Full Text]  
• Staats, H. F., Ennis, F. A. Jr. (1999). IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered with Protein Immunogens. J. Immunol. 162: 6141-6147 [Abstract] [Full Text]  
• Yumoto, H., Nakae, H., Fujinaka, K., Ebisu, S., Matsuo, T. (1999). Interleukin-6 (IL-6) and IL-8 Are Induced in Human Oral Epithelial Cells in Response to Exposure to Periodontopathic Eikenella corrodens. Infect. Immun. 67: 384-394 [Abstract] [Full Text]  
• Giuliani, M. M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R., Pizza, M. (1998). Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity. J. Exp. Med. 187: 1123-1132 [Abstract] [Full Text]  
• Nataro, J. P., Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201 [Abstract] [Full Text]  
• Yamamoto, S., Kiyono, H., Yamamoto, M., Imaoka, K., Yamamoto, M., Fujihashi, K., Van Ginkel, F. W., Noda, M., Takeda, Y., McGhee, J. R. (1997). A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94: 5267-5272 [Abstract] [Full Text]  
• Yamamoto, S., Takeda, Y., Yamamoto, M., Kurazono, H., Imaoka, K., Yamamoto, M., Fujihashi, K., Noda, M., Kiyono, H., McGhee, J. R. (1997). Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity. J. Exp. Med. 185: 1203-1210 [Abstract] [Full Text]